Ilaris
NDC 0078-0734, canakinumab, injection, solution, from Novartis Pharmaceuticals Corporation.
- Product NDC
- 0078-0734
- Status
- Listed
- Labeler
- Novartis Pharmaceuticals Corporation
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA125319
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0734 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CANAKINUMAB150 mg/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0078-0734-61 | 00078073461 | 1 VIAL, SINGLE-USE in 1 CARTON (0078-0734-61) / 1 mL in 1 VIAL, SINGLE-USE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7d271f3b-e4f9-4d80-8dcf-28d49123f80eMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0078-0734
Use it
Look up 0078-0734 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0734 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0078-0734. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.